The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Rheumatic Heart Disease

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Rheumatic Heart Disease


High impact information on Rheumatic Heart Disease


Chemical compound and disease context of Rheumatic Heart Disease


Biological context of Rheumatic Heart Disease


Anatomical context of Rheumatic Heart Disease


Gene context of Rheumatic Heart Disease


Analytical, diagnostic and therapeutic context of Rheumatic Heart Disease


  1. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. Ellinor, P.T., Low, A.F., Patton, K.K., Shea, M.A., Macrae, C.A. J. Am. Coll. Cardiol. (2005) [Pubmed]
  2. Clinical significance of incomplete tricuspid valve closure seen on two-dimensional echocardiography. Gibson, T.C., Foale, R.A., Guyer, D.E., Weyman, A.E. J. Am. Coll. Cardiol. (1984) [Pubmed]
  3. Factors influencing thromboembolic complications in Omniscience cardiac valve patients. Dewall, R., Pelletier, L.C., Panebianco, A., Hicks, G., Schuster, B., Bonan, R., Martineau, J.P., Yip, L. Eur. Heart J. (1984) [Pubmed]
  4. Rheumatic fever: autoantibodies against a variety of cardiac, nuclear, and streptococcal antigens. Eichbaum, Q.G., Hughes, E.J., Epstein, J.E., Beatty, D.W. Ann. Rheum. Dis. (1995) [Pubmed]
  5. Antibody levels and in vitro lymphoproliferative responses to Streptococcus pyogenes erythrogenic toxin A and mitogen of patients with rheumatic fever. Bahr, G.M., Yousof, A.M., Behbehani, K., Majeed, H.A., Sakkalah, S., Souan, K., Jarrad, I., Geoffroy, C., Alouf, J.E. J. Clin. Microbiol. (1991) [Pubmed]
  6. HLA antigens in Turkish race with rheumatic heart disease [see comment]. Ozkan, M., Carin, M., Sönmez, G., Senocak, M., Ozdemir, M., Yakut, C. Circulation (1993) [Pubmed]
  7. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Maharaj, B., Hammond, M.G., Appadoo, B., Leary, W.P., Pudifin, D.J. Circulation (1987) [Pubmed]
  8. Platelet and coagulation function in patients with abnormal cardiac valves treated with sulphinpyrazone. Ludlam, C.A., Allan, N., Blandford, R.B., Dowdle, R., Bentley, N.J., Bloom, A.L. Thromb. Haemost. (1981) [Pubmed]
  9. A controlled study of penicillin therapy of group A streptococcal acquisitions in Egyptian families. El Kholy, A., Fraser, D.W., Guirguis, N., Wannamaker, L.W., Plikaytis, B.D., Zimmerman, R.A. J. Infect. Dis. (1980) [Pubmed]
  10. Isolated atrial amyloidosis: a clinicopathologic study indicating increased prevalence in chronic heart disease. Looi, L.M. Hum. Pathol. (1993) [Pubmed]
  11. Transfer of digoxin across the placenta and into breast milk. Chan, V., Tse, T.F., Wong, V. British journal of obstetrics and gynaecology. (1978) [Pubmed]
  12. Autoantibodies in the sera of patients with rheumatic heart disease: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis. Tontsch, D., Pankuweit, S., Maisch, B. Clin. Exp. Immunol. (2000) [Pubmed]
  13. Cytokines and immunoglobulin in rheumatic heart disease: production by blood and tonsillar mononuclear cells. Miller, L.C., Gray, E.D., Mansour, M., Abdin, Z.H., Kamel, R., Zaher, S., Regelmann, W.E. J. Rheumatol. (1989) [Pubmed]
  14. Carnitine levels in patients with chronic rheumatic heart disease. Narin, F., Narin, N., Andaç, H., Ergin, A., Coşkun, A., Ustdal, M., Ceyran, H. Clin. Biochem. (1997) [Pubmed]
  15. Management of persistent atrial fibrillation following balloon mitral valvotomy: safety and efficacy of low-dose amiodarone. Kapoor, A., Kumar, S., Singh, R.K., Pandey, C.M., Sinha, N. J. Heart Valve Dis. (2002) [Pubmed]
  16. Factors affecting the clinical response to treatment with digoxin and two calcium antagonists in patients with atrial fibrillation. Lewis, R.V., McDevitt, D.G. British journal of clinical pharmacology. (1988) [Pubmed]
  17. A circulating IgG in Chagas' disease which binds to beta-adrenoceptors of myocardium and modulates their activity. Borda, E., Pascual, J., Cossio, P., De La Vega, M., Arana, R., Sterin-Borda, L. Clin. Exp. Immunol. (1984) [Pubmed]
  18. TNF-alpha G-308A polymorphism is associated with rheumatic fever and correlates with increased TNF-alpha production. Sallakci, N., Akcurin, G., Köksoy, S., Kardelen, F., Uguz, A., Coskun, M., Ertug, H., Yegin, O. J. Autoimmun. (2005) [Pubmed]
  19. Use of aminocaproic acid (ACA) in extra-amniotic MTP in patients on anti-coagulant therapy. Kale, P.P., Shah, M.A., Pathare, A.V. Journal of postgraduate medicine. (1992) [Pubmed]
  20. Reduced apelin levels in lone atrial fibrillation. Ellinor, P.T., Low, A.F., Macrae, C.A. Eur. Heart J. (2006) [Pubmed]
  21. Frequency and significance of M-mode echocardiographic evidence of mitral valve prolapse in clinically isolated pure mitral regurgitation: analysis of 65 patients having mitral valve replacement. Waller, B.F., Maron, B.J., Del Negro, A.A., Gottdiener, J.S., Roberts, W.C. Am. J. Cardiol. (1984) [Pubmed]
  22. Diseases in urban and rural Black populations. Seftel, H.C. S. Afr. Med. J. (1977) [Pubmed]
  23. Interleukin-2 in relation to T cell subpopulations in rheumatic heart disease. Zedan, M.M., el-Shennawy, F.A., Abou-Bakr, H.M., al-Basousy, A.M. Arch. Dis. Child. (1992) [Pubmed]
  24. Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease. Narin, N., Kütükçüler, N., Ozyürek, R., Bakiler, A.R., Parlar, A., Arcasoy, M. Clin. Immunol. Immunopathol. (1995) [Pubmed]
  25. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease. Kütükçüler, N., Narin, N. Scand. J. Rheumatol. (1995) [Pubmed]
  26. Myocardial matrix metalloproteinase-3 and matrix metalloproteinase inhibitor-1 expression in congestive heart failure. Wang, X., Yang, L., Qi, F., Et Al, n.u.l.l. Zhonghua Nei Ke Za Zhi (2002) [Pubmed]
  27. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. De Marco, T., Dae, M., Yuen-Green, M.S., Kumar, S., Sudhir, K., Keith, F., Amidon, T.M., Rifkin, C., Klinski, C., Lau, D. J. Am. Coll. Cardiol. (1995) [Pubmed]
  28. The geographical distribution of multiple sclerosis, rheumatoid arthritis, rheumatic heart disease and poststreptococcal nephritis in Sardinia: climatic and socioeconomic factors. Rosati, G., Granieri, E., Pinna, L., Aiello, I., De Bastiani, P., Tola, R. J. Neurol. (1978) [Pubmed]
  29. Significantly increased levels of mannose-binding lectin (MBL) in rheumatic heart disease: a beneficial role for MBL deficiency. Schafranski, M.D., Stier, A., Nisihara, R., Messias-Reason, I.J. Clin. Exp. Immunol. (2004) [Pubmed]
  30. Enzyme immunoassay (ELISA) for the detection of anticarbohydrate antibodies in rheumatic fever and rheumatic heart disease. Wahi, V., Ganguly, N.K., Sehgal, R., Anand, I.S., Kaur, N., Chakravarti, R.N., Wahi, P.L. Jpn. J. Exp. Med. (1989) [Pubmed]
  31. Immunohistochemical localisation of neuron-binding antibodies in rheumatic heart disease. Sabherwal, U., Chopra, P. Pathology. (1987) [Pubmed]
  32. Cardiac transplantation in New Zealand: eight years experience. Lund, M., Ellis, C.J., Coverdale, H.A., Agnew, T.M., Haydock, D.A., Middleton, N.G., Whitfield, C.J., Whitlock, R.M. N. Z. Med. J. (1997) [Pubmed]
WikiGenes - Universities